Trademark: 97291156
Word
ECDEYO
Status
Pending
Status Code
731
Status Date
Wednesday, January 24, 2024
Serial Number
97291156
Mark Type
4000
Filing Date
Wednesday, March 2, 2022
Published for Opposition
Tuesday, January 24, 2023

Trademark Owner History
Amgen Inc. - Owner At Publication

Classifications
5 pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Trademark Events
Jan 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 24, 2024
Sou Extension 2 Granted
Jan 24, 2024
Sou Extension 2 Filed
Jan 24, 2024
Sou Teas Extension Received
Sep 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 6, 2023
Sou Extension 1 Granted
Sep 6, 2023
Sou Extension 1 Filed
Sep 6, 2023
Sou Teas Extension Received
Mar 21, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 21, 2022
Approved For Pub - Principal Register
Dec 14, 2022
Assigned To Examiner
Mar 7, 2022
New Application Office Supplied Data Entered
Mar 5, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24